Home

David Hung

CIK 1310880 · PRESIDENT AND CEO · last filed 2026-06-05

David Hung is a PRESIDENT AND CEO who has filed 88 SEC Form 4 insider transactions across 8 companies since 2007. The most recent filing, for NVCR, was dated Jun 5, 2026. Across all open-market trades the lifetime net is −$72.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $575.4K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$575.4K

Companies

8

Total Filings

88

Lifetime Open-Market Net

-$71.96M

Filer Profile

Reported Address
C/O NUVATION BIO, INC.
1500 BROADWAY, SUITE 1401
NEW YORK, NY 10036
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
NVCR Director 32,075 $17.94 $575.4K -$63.7K 11 2026-06-05
NUVB PRESIDENT AND CEO — $6.81 — $0 1 2026-03-03
Nuvation Bio Inc. (NUVB.WS) Delisted PRESIDENT AND CEO 59,281,054 $0.01 $302.3K $1.71M 8 2025-06-18
ESTA Director — $74.29 — $0 2 2020-05-27
MEDIVATION, INC. (MDVN) Delisted President and CEO 1,709,497 — — -$73.04M 50 2016-09-19
Acer Therapeutics Inc. (OPXAW) Delisted Director 0 — — -$123.4K 9 2011-04-07
Acer Therapeutics Inc. (OPXA) Delisted Director — — — $0 1 2007-06-21
MEDIVATION, INC. (MDV) Delisted President and CEO 1,710,711 $18.05 $30.88M -$445.0K 1 2007-03-20

Recent Filings

88 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-05 NVCR Grant (A) +11,610 $0 EDGAR
2026-06-03 NVCR Sell (S) −2,945 -$46.4K EDGAR
2026-03-03 NUVB Grant (A) — $0 EDGAR
2025-06-18 Nuvation Bio Inc. (NUVB.WS) Delisted Buy (P) +500,000 $893.5K EDGAR
2025-06-06 NVCR Grant (A) +11,215 $0 EDGAR
2025-06-04 NVCR Sell (S) −999 -$17.3K EDGAR
2025-04-08 Nuvation Bio Inc. (NUVB.WS) Delisted Buy (P) +500,000 $820.2K EDGAR
2025-03-04 Nuvation Bio Inc. (NUVB.WS) Delisted Grant (A) — $0 EDGAR
2024-06-06 NVCR Grant (A) +4,053 $0 EDGAR
2024-03-04 Nuvation Bio Inc. (NUVB.WS) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 88
Page 1 of 9
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.